Leverge R - Search Results

1

Human sympathetic activation by alpha2-adrenergic blockade with yohimbine: Bimodal, epistatic influence of cytochrome P450-mediated drug metabolism.

Le Corre P, Parmer RJ, Kailasam MT, Kennedy BP, Skaar TP, Ho H, Leverge R, Smith DW, Ziegler MG, Insel PA, Schork NJ, Flockhart DA, O'connor DT. Le Corre P, et al. Among authors: leverge r. Clin Pharmacol Ther. 2004 Aug;76(2):139-53. doi: 10.1016/j.clpt.2004.04.010. Clin Pharmacol Ther. 2004. PMID: 15289791

2

Expression of altered alpha2-adrenergic phenotypic traits in normotensive humans at genetic risk of hereditary (essential) hypertension.

Dao TT, Kailasam MT, Parmer RJ, Le HV, Le Verge R, Kennedy BP, Ziegler G, Insel PA, Wright FA, O'Connor DT. Dao TT, et al. J Hypertens. 1998 Jun;16(6):779-92. doi: 10.1097/00004872-199816060-00009. J Hypertens. 1998. PMID: 9663918

3

Cerebrospinal fluid and plasma disposition of yohimbine and 11-hydroxy-yohimbine in young and older healthy subjects, and Alzheimer's disease patients.

Le Corre PA, Peskind ER, Chevanne F, Raskind MA, Le Verge R. Le Corre PA, et al. Eur J Clin Pharmacol. 1997;52(2):135-8. doi: 10.1007/s002280050262. Eur J Clin Pharmacol. 1997. PMID: 9174683

4

Biopharmaceutics and metabolism of yohimbine in humans.

Le Corre P, Dollo G, Chevanne F, Le Verge R. Le Corre P, et al. Eur J Pharm Sci. 1999 Oct;9(1):79-84. doi: 10.1016/s0928-0987(99)00046-9. Eur J Pharm Sci. 1999. PMID: 10494000 Clinical Trial.

5

Alpha 2-adrenoceptor antagonist potencies of two hydroxylated metabolites of yohimbine.

Berlan M, Le Verge R, Galitzky J, Le Corre P. Berlan M, et al. Br J Pharmacol. 1993 Apr;108(4):927-32. doi: 10.1111/j.1476-5381.1993.tb13488.x. Br J Pharmacol. 1993. PMID: 8097957 Free PMC article.

6

Cerebrospinal fluid bioavailability and pharmacokinetics of bupivacaine and lidocaine after intrathecal and epidural administrations in rabbits using microdialysis.

Clement R, Malinovsky JM, Le Corre P, Dollo G, Chevanne F, Le Verge R. Clement R, et al. J Pharmacol Exp Ther. 1999 May;289(2):1015-21. J Pharmacol Exp Ther. 1999. PMID: 10215682

7

Clinical pharmacokinetics of levorotatory and racemic disopyramide, at steady state, following oral administration in patients with ventricular arrhythmias.

Le Corre P, Gibassier D, Descaves C, Sado P, Daubert JC, Le Verge R. Le Corre P, et al. J Clin Pharmacol. 1989 Dec;29(12):1089-96. doi: 10.1002/j.1552-4604.1989.tb03284.x. J Clin Pharmacol. 1989. PMID: 2482304 Clinical Trial.

8

Human pharmacokinetics and metabolism of disopyramide enantiomers.

Le Corre P, Gibassier D, Sado P, Le Verge R. Le Corre P, et al. Eur J Drug Metab Pharmacokinet. 1991;Spec No 3:233-7. Eur J Drug Metab Pharmacokinet. 1991. PMID: 1820885

9

Simultaneous assay of disopyramide and monodesisopropyldisopyramide enantiomers in biological samples by liquid chromatography.

Le Corre P, Gibassier D, Sado P, Le Verge R. Le Corre P, et al. J Chromatogr. 1988 Feb 26;424(2):424-9. doi: 10.1016/s0378-4347(00)81123-8. J Chromatogr. 1988. PMID: 3372636 No abstract available.

10

Non linear disposition of thiopentone following long-term infusion.

Le Corre P, Malledant Y, Tanguy M, Le Verge R. Le Corre P, et al. Eur J Drug Metab Pharmacokinet. 1993 Jul-Sep;18(3):255-9. doi: 10.1007/BF03188805. Eur J Drug Metab Pharmacokinet. 1993. PMID: 8149943

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters